Cargando…

Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)

CONTEXT: Hypertension (HTN) is a well-known modifiable risk factor for cardiovascular disease (CVD), chronic kidney disease and mortality. Positive effects of blood pressure (BP) lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdi, Hengameh, Amouzegar, Atieh, Tohidi, Maryam, Azizi, Fereidoun, Hadaegh, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289294/
https://www.ncbi.nlm.nih.gov/pubmed/30584437
http://dx.doi.org/10.5812/ijem.84769
_version_ 1783379945556279296
author Abdi, Hengameh
Amouzegar, Atieh
Tohidi, Maryam
Azizi, Fereidoun
Hadaegh, Farzad
author_facet Abdi, Hengameh
Amouzegar, Atieh
Tohidi, Maryam
Azizi, Fereidoun
Hadaegh, Farzad
author_sort Abdi, Hengameh
collection PubMed
description CONTEXT: Hypertension (HTN) is a well-known modifiable risk factor for cardiovascular disease (CVD), chronic kidney disease and mortality. Positive effects of blood pressure (BP) lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials. EVIDENCE ACQUISITION: This review focuses on the key findings derived from the Tehran lipid and glucose study (TLGS) papers on different aspects of BP and HTN. RESULTS: A prevalence of 23% for HTN has been reported in the TLGS population, aged ≥ 20 years. Over a decade long follow-up, the crude incidence rate (95% CI) of new-onset HTN defined as systolic BP (SBP) ≥ 140 mmHg and/or diastolic BP (DBP) ≥ 90 mmHg, and not using antihypertensive medication was 33.63 (32.0 - 35.3) per 1000 person-years. Age, baseline SBP and body mass index were significant risk factors for development of isolated systolic HTN; regarding isolated diastolic HTN, baseline DBP and waist circumference were recognized as important risk factors whereas age, female gender and marriage were shown to be protective factors. SBP decreased significantly in both diabetic and non-diabetic participants; DBP showed a non-significant decrease in diabetic men and a statistically significant decrease in non-diabetic men. Among women, both those with and without diabetes (DM) generally experienced statistically significant decreases in DBP. Cox proportional hazard models showed that neither SBP nor DBP were associated with incident DM in the total population and in either gender, separately. All BP components were associated with CVD and all-cause mortality in the middle-aged population. Contribution of HTN to cerebrovascular events was also documented in the TLGS participants, aged ≥ 50 years. CONCLUSIONS: Several important findings regarding BP/HTN have been derived from the TLGS. According to data regarding the prevalence and incidence of preHTN and HTN and their contribution to cardiovascular morbidity and mortality in the TLGS population as a representative sample of Tehranian population, it is recommended that interventions be prioritized for lifestyle modifications for the prevention and appropriate management of preHTN/HTN.
format Online
Article
Text
id pubmed-6289294
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-62892942018-12-24 Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS) Abdi, Hengameh Amouzegar, Atieh Tohidi, Maryam Azizi, Fereidoun Hadaegh, Farzad Int J Endocrinol Metab Review Article CONTEXT: Hypertension (HTN) is a well-known modifiable risk factor for cardiovascular disease (CVD), chronic kidney disease and mortality. Positive effects of blood pressure (BP) lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials. EVIDENCE ACQUISITION: This review focuses on the key findings derived from the Tehran lipid and glucose study (TLGS) papers on different aspects of BP and HTN. RESULTS: A prevalence of 23% for HTN has been reported in the TLGS population, aged ≥ 20 years. Over a decade long follow-up, the crude incidence rate (95% CI) of new-onset HTN defined as systolic BP (SBP) ≥ 140 mmHg and/or diastolic BP (DBP) ≥ 90 mmHg, and not using antihypertensive medication was 33.63 (32.0 - 35.3) per 1000 person-years. Age, baseline SBP and body mass index were significant risk factors for development of isolated systolic HTN; regarding isolated diastolic HTN, baseline DBP and waist circumference were recognized as important risk factors whereas age, female gender and marriage were shown to be protective factors. SBP decreased significantly in both diabetic and non-diabetic participants; DBP showed a non-significant decrease in diabetic men and a statistically significant decrease in non-diabetic men. Among women, both those with and without diabetes (DM) generally experienced statistically significant decreases in DBP. Cox proportional hazard models showed that neither SBP nor DBP were associated with incident DM in the total population and in either gender, separately. All BP components were associated with CVD and all-cause mortality in the middle-aged population. Contribution of HTN to cerebrovascular events was also documented in the TLGS participants, aged ≥ 50 years. CONCLUSIONS: Several important findings regarding BP/HTN have been derived from the TLGS. According to data regarding the prevalence and incidence of preHTN and HTN and their contribution to cardiovascular morbidity and mortality in the TLGS population as a representative sample of Tehranian population, it is recommended that interventions be prioritized for lifestyle modifications for the prevention and appropriate management of preHTN/HTN. Kowsar 2018-10-20 /pmc/articles/PMC6289294/ /pubmed/30584437 http://dx.doi.org/10.5812/ijem.84769 Text en Copyright © 2018, International Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Review Article
Abdi, Hengameh
Amouzegar, Atieh
Tohidi, Maryam
Azizi, Fereidoun
Hadaegh, Farzad
Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
title Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
title_full Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
title_fullStr Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
title_full_unstemmed Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
title_short Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
title_sort blood pressure and hypertension: findings from 20 years of the tehran lipid and glucose study (tlgs)
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289294/
https://www.ncbi.nlm.nih.gov/pubmed/30584437
http://dx.doi.org/10.5812/ijem.84769
work_keys_str_mv AT abdihengameh bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs
AT amouzegaratieh bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs
AT tohidimaryam bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs
AT azizifereidoun bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs
AT hadaeghfarzad bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs